Circ Heart Fail -- Table of Contents (2 [2])

Volume 2, Issue 2; March, 2009

Editorials
Original Articles
Advances in Heart Failure
Development of Therapeutics for Heart Failure

To see an article, click its "Full Text" or "PDF" link. To review many abstracts, check the boxes to the left of the titles you want, and click the "Get All Checked Abstract(s)" button. To see one abstract at a time, click its "Abstract" link.

button_lock_image article is free immediately upon publication

	Editorials
	Digoxin: Quo Vadis? John G.F. Cleland and Damien Cullington Circ Heart Fail. 2009;2:81-85, doi:10.1161/CIRCHEARTFAILURE.109.859322 Extract \| Full Text \| PDF
	Serum Cystatin C, Renal Filtration Function, and Left Ventricular Remodeling Mark D. McMurray, Justin E. Trivax, and Peter A. McCullough Circ Heart Fail. 2009;2:86-89, doi:10.1161/CIRCHEARTFAILURE.109.856393 Extract \| Full Text \| PDF
	Original Articles
	Digoxin Therapy Does Not Improve Outcomes in Patients With Advanced Heart Failure on Contemporary Medical Therapy Vasiliki V. Georgiopoulou, Andreas P. Kalogeropoulos, Grigorios Giamouzis, Syed A. Agha, Mohammad A. Rashad, Sana Waheed, Sonjoy Laskar, Andrew L. Smith, and Javed Butler Circ Heart Fail. 2009;2:90-97; published online before print February 10 2009, doi:10.1161/CIRCHEARTFAILURE.108.807032 Abstract \| Full Text \| PDF \| Clinical Perspective
	Association of Cystatin C With Left Ventricular Structure and Function: The Dallas Heart Study Parag C. Patel, Colby R. Ayers, Sabina A. Murphy, Ronald Peshock, Amit Khera, James A. de Lemos, Jody A. Balko, Sachin Gupta, Pradeep P.A. Mammen, Mark H. Drazner, and David W. Markham Circ Heart Fail. 2009;2:98-104; published online before print February 10 2009, doi:10.1161/CIRCHEARTFAILURE.108.807271 Abstract \| Full Text \| PDF \| Clinical Perspective
	Prevalence of Left Ventricular Diastolic Dysfunction in a General Population Tatiana Kuznetsova, Lieven Herbots, Begoña López, Yu Jin, Tom Richart, Lutgarde Thijs, Arantxa González, Marie-Christine Herregods, Robert H. Fagard, Javier Díez, and Jan A. Staessen Circ Heart Fail. 2009;2:105-112; published online before print February 10 2009, doi:10.1161/CIRCHEARTFAILURE.108.822627 Abstract \| Full Text \| PDF \| Data Supplement \| Clinical Perspective
	Determining the Preferred Percent-Predicted Equation for Peak Oxygen Consumption in Patients With Heart Failure Ross Arena, Jonathan Myers, Joshua Abella, Sherry Pinkstaff, Peter Brubaker, Brian Moore, Dalane Kitzman, Mary Ann Peberdy, Daniel Bensimhon, Paul Chase, Daniel Forman, Erin West, and Marco Guazzi Circ Heart Fail. 2009;2:113-120; published online before print February 10 2009, doi:10.1161/CIRCHEARTFAILURE.108.834168 Abstract \| Full Text \| PDF \| Data Supplement \| Clinical Perspective
	Pheochromocytoma-Induced Cardiomyopathy is Modulated by the Synergistic Effects of Cell-Secreted Factors Hector R. Mobine, Aaron B. Baker, Libin Wang, Hiroko Wakimoto, Kurt C. Jacobsen, Christine E. Seidman, J.G. Seidman, and Elazer R. Edelman Circ Heart Fail. 2009;2:121-128; published online before print February 10 2009, doi:10.1161/CIRCHEARTFAILURE.108.813261 Abstract \| Full Text \| PDF \| Clinical Perspective
	Inhibition of Protein Kinase C–β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy Kim A. Connelly, Darren J. Kelly, Yuan Zhang, David L. Prior, Andrew Advani, Alison J. Cox, Kerri Thai, Henry Krum, and Richard E. Gilbert Circ Heart Fail. 2009;2:129-137; published online before print February 10 2009, doi:10.1161/CIRCHEARTFAILURE.108.765750 Abstract \| Full Text \| PDF \| Data Supplement \| Clinical Perspective
	Advances in Heart Failure
	The Effects of Vasodilators in Pulmonary Hypertension: Pulmonary Vascular or Peripheral Vascular? Stuart Rich Circ Heart Fail. 2009;2:145-150, doi:10.1161/CIRCHEARTFAILURE.108.805374 Extract \| Full Text \| PDF
	Heart Failure as a Multiple Hormonal Deficiency Syndrome Luigi Saccà Circ Heart Fail. 2009;2:151-156, doi:10.1161/CIRCHEARTFAILURE.108.821892 Extract \| Full Text \| PDF
	Development of Therapeutics for Heart Failure
	Small Animal Models of Heart Failure: Development of Novel Therapies, Past and Present Richard D. Patten and Monica R. Hall-Porter Circ Heart Fail. 2009;2:138-144, doi:10.1161/CIRCHEARTFAILURE.108.839761 Extract \| Full Text \| PDF

Spotlight

TOC Spotlight File

Volume 2, Issue 2; March, 2009

Editorials

Digoxin: Quo Vadis?

Serum Cystatin C, Renal Filtration Function, and Left Ventricular Remodeling

Original Articles

Digoxin Therapy Does Not Improve Outcomes in Patients With Advanced Heart Failure on Contemporary Medical Therapy

Association of Cystatin C With Left Ventricular Structure and Function: The Dallas Heart Study

Prevalence of Left Ventricular Diastolic Dysfunction in a General Population

Determining the Preferred Percent-Predicted Equation for Peak Oxygen Consumption in Patients With Heart Failure

Pheochromocytoma-Induced Cardiomyopathy is Modulated by the Synergistic Effects of Cell-Secreted Factors

Inhibition of Protein Kinase C–β by Ruboxistaurin Preserves Cardiac Function and Reduces Extracellular Matrix Production in Diabetic Cardiomyopathy

Advances in Heart Failure

The Effects of Vasodilators in Pulmonary Hypertension: Pulmonary Vascular or Peripheral Vascular?

Heart Failure as a Multiple Hormonal Deficiency Syndrome

Development of Therapeutics for Heart Failure

Small Animal Models of Heart Failure: Development of Novel Therapies, Past and Present

Spotlight